A Dose Escalation Study of SHP2 Inhibitor in Patients With Solid Tumors Harboring KRAS of EGFR Mutations

Clinical trial NCT05163028 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05163028
Sponsor: HUYABIO International, LLC.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer Colorectal Cancer Pancreatic Cancer Solid Tumor Cancer Cancer of Pancreas Cancer of Colon

Start date: 2021-12-13
Primary completion: 2026-12-31
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.